Transcatheter Cardiovascular Therapeutics

Improved outcomes with CoreValve in extreme-risk patients

SAN FRANCISCO – Transcatheter aortic valve replacement with the self-expanding CoreValve in patients at extreme surgical risk significantly reduced the rate of death or major stroke at 1 year, from...